🔴 GT Biopharma is trading 6% down — cause remains unconfirmed

GT Biopharma is trading 6.03% down at $6.08 on October 1, 2026; the cause of the decline remains unconfirmed.

• No clear company-specific announcement explaining the decline surfaced; GT Biopharma’s latest identified major news was earlier, not on October 1.
• Reuters reported elevated U.S. Treasury yields and a mixed macro backdrop on October 1. Major indices in the supplied context were higher, so broad-market direction does not clearly explain the drop.